14 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... EricsMedicalLectures/featured ... #medications #table ... #comparison #management ... endocrinology #dm2
Intern Pocket Cards - Inpatient Bowel Regimen Guide
Osmotic agents (draws water into bowel, thereby loosening stool
Bowel Regimen Guide ... Osmotic agents ... #pharmacology #table ... #agents #internship ... #comparison
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Mellitus Type 2 Inpatient ... Medication Guide ... Diabetes #Mellitus #DM2 ... #pharmacology #comparison ... #table #endocrinology
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
• Neuropathic agents ... SatyaPatelMD Full Inpatient ... #pharmacology #agents ... #internship #guide ... #comparison
Intern Pocket Cards - Inpatient Blood Pressure Management Guide
ß-blockers:
 • Metoprolol, Carvedilol, Labetalol
 • Bradycardia, heart
Pocket Cards - Inpatient ... Pressure Management Guide ... #pharmacology #table ... #agents #internship ... #comparison
Intern Pocket Cards - Inpatient Anti-Emetics Guide
Serotonin antagonists:
 • Ondansetron (Zofran), Granisetron (Kytril, Sancuso) - Headache,
Pocket Cards - Inpatient ... Anti-Emetics Guide ... #pharmacology #table ... #agents #internship ... #guide
Cardiac Event Monitors
 • Holter Monitor - Records every heart beat for 24-48 hours
 • Loop/Event
and after every patient ... triggered events ... triggered events ... telemetry #devices #comparison ... #table
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
consider using the agent ... Consider as 2nd agent ... pathways • 2nd-line agent ... management #treatment #comparison ... #table
Treatment Algorithm for Active Proliferative Lupus Nephritis (Class III/IV or Mixed Class III/IV + V)
Induction Therapy
Treatment Algorithm ... Therapy (Induction Agent ... Regimen) 0.5-1 g/m2 ... Kidney Protective Measures ... #Treatment #Algorithm
Rapid, increasing signs of extrapyramidal symptoms (EPS) is an important key feature of NMS. EPS, associated
important key feature ... laboratory profile of a patient ... NeurolepticMalignant #Comparison ... #Table